|
ORGANIZATION AND BUSINESS (Details Textual) (USD $)
|
12 Months Ended | 1 Months Ended | |
|---|---|---|---|
|
Dec. 31, 2012
|
Dec. 31, 2011
|
Mar. 31, 2010
Limited Liability Company Agreement [Member]
|
|
| Entity, Principal Product Proven Effeciency Percentage Description | Our flagship brand is Cold-EEZE Cold Remedy and our principal product is Cold-EEZE zinc gluconate lozenges, proven in clinical studies to reduce the duration of the common cold by 42%. | ||
| Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage | 50.00% | ||
| Working Capital Before Implementation Of Strategy | $ 5,300,000 | ||
| Working Capital After Implementation Of Strategy | 5,800,000 | ||
| Strategy Description | As a consequence of these investments, our revenues have increased an aggregate of 54.5% from Fiscal 2010 to Fiscal 2012 | ||
| Increase Of Working Capital | $ 467,000 | ||
| X | ||||||||||
|
- Definition
Description about the efficiency of entities principal product proven in studies. No definition available.
|
| X | ||||||||||
|
- Definition
It defines increase in working capital during the period. No definition available.
|
| X | ||||||||||
|
- Definition
It represents the revenues increased. No definition available.
|
| X | ||||||||||
|
- Definition
It reflects from the after implementation of strategy No definition available.
|
| X | ||||||||||
|
- Definition
Represents the implement of strategy No definition available.
|
| X | ||||||||||
|
- Definition
Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|